Panel 10 diversified collaboration strategy for successful commercialization in Asia Summit
The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit (ALHSICS) was held from 31 October 2023 to 1 November 2023 in Singapore. This summit was organized by ASK Health Asia, SingHealth Duke-NUS Global Health Institute, and in partnership with the World Economic Forum.
The two-days summit has gathered industry leaders and visionaries of various backgrounds from Asia. Eight different topics were discussed to create an in-depth and invaluable forum about the latest innovative technologies and trends that shape the health and life sciences landscape.
It is with great honor that our CEO, Mr Sean Shi was invited to join this prestigious summit as a panelist together with other distinguished panelists of various backgrounds from the government bodies, international organizations, biotech companies, and medical institutions. The speakers gathered insights and emphasized the importance of partnerships between startups, established corporations, educational institutions, and healthcare providers. This is to cultivate and broaden the possibility of open innovation, as it lays the essential foundation for the future of healthcare in our constantly growing and aging population1.
Stay tuned for more exciting updates on our journey as we continue to go beyond the limits in health and life sciences innovation!
Reference link:1https://www.prnewswire.com/apac/news-releases/the-2023-asia-health-and-life-sciences-innovation-and-cooperation-summit-delivered-insights-on-the-future-of-healthcare-301981156.html
About Ask Health Asia
ASK Health Asia is an Asia based think tank, consultancy, and venture builder in healthcare. Headquartered in Singapore, ASK Health Asia has extensive experience and operations in Southeast Asia, Mainland China, and Macau, with close partnership in India, Japan, Korea, Australia, and Middle East. ASK Health is a premier catalyst for health systems transformation in Asia. Through in-depth research, consultancy, platform development, solution co-creation and resource connection, we work closely with development partner, governments, and industry leaders to jointly capture growth opportunities from new health policies and provide innovative solutions to the economies across Asia.
Source ASK Health Asia: http://www.askhealthasia.com/ http://www.askhealth.com.cn/
Vaccine is a biological preparation which protects an individual and its community with immunity against a specific infection. It contains substances that resembles a disease-causing microorganism often made from attenuated or inactive forms of the pathogen, its toxins or surface proteins.
Influenza or more commonly known as flu is a contagious respiratory infection caused by the influenza viruses. It is typically spread through small airborne droplets when an individual sneezes, coughs or talks.
A protein-based COVID-19 vaccine made by Sinopharm, when given as a booster after two doses of an earlier shot from the Chinese firm, elicited a stronger antibody response against the Omicron variant than a third dose of the original, a study showed.